Skip to main content
Give
Division of Nephrology
DepartmentsDepartment of MedicineDivisionsDivision of NephrologyPublications2011 Divisional Bibliography

2011 Divisional Bibliography

Peer Reviewed

  1. Bis JC, Kavousi M, Franceschini N, Isaacs A, Abecasis GR, Schminke U, Post WS, Smith AV, Cupples LA, Markus HS, Schmidt R, Huffman JE, Lehtimäki T, Baumert J, Münzel T, Heckbert SR, Dehghan A, North K, Oostra B, Bevan S, Stoegerer EM, Hayward C, Raitakari O, Meisinger C, Schillert A, Sanna S, Völzke H, Cheng YC, Thorsson B, Fox CS, Rice K, Rivadeneira F, Nambi V, Halperin E, Petrovic KE, Peltonen L, Wichmann HE, Schnabel RB, Dörr M, Parsa A et al.  Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet. 2011 Sep 11.
  2. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, Van Huysse JW, Zhang J, Wier WG. How NaCl raises blood pressure: A new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol. 2011 Nov 4. [Epub ahead of print]
  3. Böger CA, Chen MH, Tin A, Olden M, Köttgen A, de Boer IH, Fuchsberger C, O'Seaghdha CM, Pattaro C, Teumer A, Liu CT, Glazer NL, Li M, O'Connell JR, Tanaka T, Peralta CA, Kutalik Z, Luan J, Zhao JH, Hwang SJ, Akylbekova E, Kramer H, van der Harst P, Smith AV, Lohman K, de Andrade M, Hayward C, Kollerits B, Tönjes A, Aspelund T, Ingelsson E, Eiriksdottir G, Launer LJ, Harris TB, Shuldiner AR, Mitchell BD, Arking DE, Franceschini N, Boerwinkle E, Egan J, Hernandez D, Reilly M, Townsend RR, Lumley T, Siscovick DS, Psaty BM, Kestenbaum B, Haritunians T, Bergmann S, Vollenweider P, Waeber G, Mooser V, Waterworth D, Johnson AD, Florez JC, Meigs JB, Lu X, Turner ST, Atkinson EJ, Leak TS, Aasarød K, Skorpen F, Syvänen AC, Illig T, Baumert J, Koenig W, Krämer BK, Devuyst O, Mychaleckyj JC, Minelli C, Bakker SJ, Kedenko L, Paulweber B, Coassin S, Endlich K, Kroemer HK, Biffar R, Stracke S, Völzke H, Stumvoll M, Mägi R, Campbell H, Vitart V, Hastie ND, Gudnason V, Kardia SL, Liu Y, Polasek O, Curhan G, Kronenberg F, Prokopenko I, Rudan I, Arnlöv J, Hallan S, Navis G; CKDGen Consortium, Parsa A, Ferrucci L, Coresh J, Shlipak MG, Bull SB, Paterson NJ, Wichmann HE, Wareham NJ, Loos RJ, Rotter JI, Pramstaller PP, Cupples LA, Beckmann JS, Yang Q, Heid IM, Rettig R, Dreisbach AW, Bochud M, Fox CS, Kao WH. CUBN is a gene locus for albuminuria. J Am Soc Nephrol. 2011 Mar;22(3):555-70.
  4. Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, Selhub J, Jacques PF, Cole E, Gravens-Mueller L, House AA, Kew C, McKenney JL, Pacheco-Silva A, Pesavento T, Pirsch J, Smith S, Solomon S, Weir M. Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial. Circulation. 2011;123:1763-1770.
  5. Cunnigham, R., Weinman, E.J., and Blaine, J.: Renal Phosphate Transport. Adv. Chronic Kidney Dis. 18:77-84, 2011.
  6. Dalrymple LS*, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, Seliger S, Siscovick D, Newman AB, Fried L#.  “Chronic kidney disease and the risk of end-stage renal disease versus death.”  J Gen Intern Med. 2011;26(4):379-85
  7. deFilippi CR,  Christenson RH, Kop WJ, Gottdiener JS, Zhan M, Seliger SL..  “Left Ventricular Ejection Fraction Assessment in Older Adults: An Adjunct to Natriuretic Peptide Testing to Identify Risk of New-Onset Heart Failure and Cardiovascular Death?”  J Am Coll Cardiol 2011; 58(14): 1497-506. 
  8. Donowitz, M., Singh, S., Singh, P., Chakraborty, M., Chen, Y., Murtazina, R., Gucek, M., Cole, R., Zachos, N., Salahuddin, F., Kovbasnjuk, O., Broere, N., Smalley-Freed, W., Reynolds, A., Hubbard, A., Seidler,U., Weinman, E.J., deJonge, H., Hogema, B., and Li, X.: Alternations in the Proteome of the NHERF2 Knockout Mouse Jejunal Brush Border Membrane Vesicles. Physiol. Genomics 43:674-684, 2011.
  9. Drachenberg CB, Torrealba JR, Nankivell BJ, Rangel EB, Bajema IM, Kim DU, Arend L, Bracamonte ER, Bromberg JS, Bruijn JA, Cantarovich D, Chapman JR, Farris AB, Gaber L, Goldberg JC, Haririan A, Honsová E, Iskandar SS, Klassen DK, Kraus E, Lower F, Odorico J, Olson JL, Mittalhenkle A, Munivenkatappa R, Paraskevas S, Papadimitriou JC, Randhawa P, Reinholt FP, Renaudin K, Revelo P, Ruiz P, Samaniego MD, Shapiro R, Stratta RJ, Sutherland DE, Troxell ML, Voska L, Seshan SV, Racusen LC, Bartlett ST. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant. 2011 Sep;11(9):1792-802.
  10. Edwards A, Cao C, Pallone TL. Cellular mechanisms underlying nitric oxide-induced vasodilation of descending vasa recta. Am J Physiol Renal Physiol.  2011 Feb;300(2):F441-56.
  11. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang SJ, Pihur V, Vollenweider P, O'Reilly PF, Amin N, Bragg-Gresham JL, Teumer A, Glazer NL, Launer L, Hua Zhao J, Aulchenko Y, Heath S, Sõber S, Parsa A et al (23 rd of 351 authors, Parsa A, led the Amish Studies GWAS related to the meta-analysis and served on the Steering Committee).  Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.  The International Consortium for Blood Pressure Genome-Wide Association Studies. Nature. 2011 Sep 11.
  12. Fayek SA, Keenan J, Haririan A, Cooper M, Barth RN, Schweitzer E, Bromberg JS, Bartlett ST, Philosophe B. Ureteral Stents Are Associated With Reduced Risk of Ureteral Complications After Kidney Transplantation: A Large Single Center Experience. Transplantation. 2011 Dec 15. [Epub ahead of print]
  13. Fox ER, Young JH, Li Y, Dreisbach AW, Keating BJ, Musani SK, Liu K, Morrison AC, Ganesh S, Kutlar A, Ramachandran VS, Polak JF, Fabsitz RR, Dries DL, Farlow DN, Redline S, Adeyemo A, Hirschorn JN, Sun YV, Wyatt SB, Penman AD, Palmas W, Rotter JI, Townsend RR, Doumatey AP, Tayo BO, Mosley TH Jr, Lyon HN, Kang SJ, Rotimi CN, Cooper RS, Franceschini N, Curb JD, Martin LW, Eaton CB, Kardia SL, Taylor HA, Caulfield MJ, Ehret GB, Johnson T; International Consortium for Blood Pressure Genome-wide Association Studies (ICBP-GWAS), Chakravarti A, Zhu X, Levy D, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang SJ, Pihur V, Vollenweider P, O'Reilly PF, Amin N, Bragg-Gresham JL, Teumer A, Glazer NL, Launer L, Zhao JH, Aulchenko Y, Heath S, Sõber S, Parsa A et al.  Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet. 2011 Apr 8.
  14. Gieger C, Radhakrishnan A,  Cvejic A, Tang W, Porcu E, Pistis G, Serbanovic-Canic J, Elling U, Goodall A, Labrune Y, Lopez L, Mägi R, Meacham S, Okada Y, Pirastu N, Sorice R, Teumer A, Voss K, Zhang W, Bis J, Ellinghaus D, Gögele M, Jan Hottenga J, Langenberg C, Kovacs P, O'Reilly P, Shin S, Esko T, Hartiala J, Kanoni S, Murgia F, Parsa A et al (total of 161 authors, Parsa led the full GWAS for one of the contributing cohorts to this multi-national effort). Sixty-eight genetic loci uncover new gene functions in megakaryopoiesis and platelet formation. Nature. 2011 Nov 30;480(7376):201-8
  15. Haririan A, Metireddy M, Cangro C, Nogueira JM, Rasetto F, Cooper M, Klassen DK, Weir MR. Association of serum uric Acid with graft survival after kidney transplantation: a time-varying analysis. Am J Transplant. 2011 Sept; 11(9):1943-50.
  16. Haririan A., Papadimitriou JC. The need for better understanding of transplant glomerulitis. Am J Transplant. 2011 Apr;11(4):866.. Epub 2011 Mar 14.
  17. Hsu C, Propert K, Xie, D, Hamm L, He J, Miller E, Akinlolu O, Shlipak M, Townsend R, Weir M, et al. Measured GFR Does Not Outperform Estimated GFR in Predicting CKD-related Complications. J Am Soc Nephrol 2011(22):1931-1937.
  18. Jamerson KA, Devereux R, Bakris GL, Dahlof B, Velazquez EJ, Weir M, et al. Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control. Hypertension. 2011 Feb; 57(2):174-9.
  19. Khurana S, Raufman JP, Pallone TL. Bile acids regulate cardiovascular function. Clin Transl Sci. 2011 Jun;4(3):210-8.
  20. Kop WJ, Seliger SL, Fink JC, Katz R, Odden MC, Fried LF, Rifkin DE, Sarnak MJ, Gottdiener JS. “Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes.”  Clin J Am Soc Nephrol 2011 Apr;6(4):834-44.
  21. Krum H, Swergold G, Gammaitoni A, Peloso PM, Smugar SS, Curtis SP, Brater DC, Wang H, Kaur A, Laine L, Weir MR, Cannon CP. Blood Pressure and Cardiovascular Outcomes in Patients Taking Nonsteroidal Antiinflammatory Drugs. Cardiovasc Ther. 2011 May. (Epub ahead of print)
  22. Kurella Tamura M, Xie D, Yaffe K, Cohen DL, Teal V, Kasner SE, Messé SR, Sehgal AR, Kusek J, DeSalvo KB, Cornish-Zirker D, Cohan J, Seliger SL, Chertow GM, Go AS.  “Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.”  Clin J Am Soc Nephrol 2011 Feb;6(2):248-56.
  23. Mitchell GF, Verwoert GC, Tarasov KV, Isaacs A,  Smith AV, Yasmin, Rietzschel ER, Tanaka T, Liu Y, Parsa A et al. (Parsa A, listed as 10th of 74 authors, led the Amish GWAS effort within the meta-GWAS effort and served on the steering committee). Common genetic variation in the BCL11B gene enhancer is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: The AortaGen Consortium.   Circ Cardiovasc Genet. 2011 Nov 8. [Epub ahead of print]
  24. McMahon G, Weir MR, Li XC, Mandelbrot DA. The Evolving Role of mTOR Inhibition in Transplantation Tolerance. J AM Soc Nephrol 2011 (22): 408-415.
  25. Mindikoglu AL, Raufman JP, Seliger SL, Howell CD, Magder LS.  “Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.”  Transplant Proc 2011 Sep;43(7):2669-77
  26. Montasser ME, Douglas JA, Roy-Gagnon M, Van Hout CV, Weir MR, et. al. Determinants of Blood Pressure Response to Low-Salt Intake in a Healthy Adult Population. J Clin Hypertens (Greenwich). 2011;13:795-800.
  27. Onukwugha E, Mullins CD, Loh FE, Saunders E, Shaya FT, Weir MR. Readmissions after unauthorized discharges in the cardiovascular setting. Med Care. 2011 Feb; 49(2):215-24.
  28. Parsa A, Chang YP, Kelly RJ, Corretti MC, Ryan KA, Robinson SW, Gottlieb SS, Kardia SL, Shuldiner AR, Liggett SB. Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin Transl Sci. 2011 Feb;4(1):17-23.
  29. Parsa A, Brown E, Weir, MR, Fink J, Shuldiner AR, Mitchell B, McArdle P. Genotype based change in serum uric acid affect blood pressure. Kidney Int. 2011 Dec 21(81):502-507.
  30. Sajadi M, Shakeri N, Talwani R, Howell CD, Pakyz R, Redfield RR, Parsa A. IL28B genotype does not correlate with HIV control in African Americans. Clin Transl Sci. 2011 Aug;4(4):282-4
  31. Salyer, S., Lesousky, N., Weinman, E.J., Clark, B.J., Lederer, E.D., and Khundmiri, S.J.: Dopamine Regulation of Na+-K+ ATPase Requires the PDZ-2 Domain of Sodium Hydrogen Regulatory Factor – 1 (NHERF-1) in Opossum Kidney Cells. Amer. J. Physiol. Cell Physiol. 300:C425-434, 2011. 
  32. Schmieder RE, Bakris G, Weir MR. Telmisartan in incipient and overt diabetic renal disease. J Nephrol. 2011 May-June;24(3):263-73.
  33. Seliger SL, Zhang AD, Weir MR, Walker L, Hsu VD, Parsa A, Diamantidis CJ, Fink JC. Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease. Kidney Int. 2011 Mar 9 (80): 288-294.
  34. Scialla J, Leonard MB, Townsend R, Appel L, Wolf M, Budoff MJ, Chen J, Lustigova E, Gadegbeku CA, Glenn M, Hanish A, Raj D, Rosas SE, Seliger SL, Weir MR, Parekh RS on behalf of the CRIC Study Group. Correlates of Osteoprotegerin and Association with Aortic Pulse Wave Velocity in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol 6:2612-2619, 2011.
  35. Sethi A, Estrella MM, Ugarte R, Atta MG. Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era. Int J Nephrol Renovasc Dis. 2011;4:139-44.
  36. Sharma AM, Weir MR. The role of angiotensin receptor blockers in diabetic nephropathy. Postgrad Med. 2011 May;123(3):109-21.
  37. van den Broek KC, Defilippi CR, Christenson RH, Seliger SL, Gottdiener JS, Kop WJ.  “Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality.” Am J Cardiol 2011 Mar 1;107(5):723-9.
  38. Wali RK, Lyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, et al. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials. Circ Heart Fail. 2011 Jan 1;4 (1): 18-26.
  39. Weinman, E.J., Steplock, D., Shenolikar, S., and Blanpied, T.A.: Dynamics of PTH-induced disassembly of Npt2a/NHERF-1 complexes in living OK cells.  Amer. J. Physiol. Renal Physiol. 300:F231-F235, 2011.
  40. Weinman, E.J., Biswas, R., Steplock, D., Wang, P., Lau, Y-S., Desir, G.V., and Shenolikar, S.: Increased renal dopamine and the acute renal adaptation to a high phosphate diet. Amer. J. Physiol. Renal Physiol. 300:F1123-F1129, 2011.
  41. Weinman. E.J., Steplock, D., Shenolikar, S., and Biswas, R. Fibroblast Growth Factor-23-mediated Inhibition of Renal Phosphate Transport in Mice Requires Sodium-Hydrogen Exchanger Regulatory Factor-1 (NHERF-1) and Synergizes with Parathyroid Hormone. J Biol Chem. 286:37216-37221.2011.
  42. Weir MR, Mulgaonkar S, Chan L, Shidban H, et al. Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial. Kid Int. 2011; (79) 897-907.
  43. Weir MR, Punzi HA, Flack JM, Stoakes KA, et al. A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension. Postgrad Med. 2011 Jan;123 (1):80-7.
  44. Weir MR, Bartlett ST, Drachenberg CB. Eosinophilia as an early indicator of pancreatic allograft rejection. Clin Transplant. 2011 Apr 7. (Epub ahead of print)
  45. Weir MR, Zappe D, Orloski LA, Sowers JR. How early should blood pressure control be achieved for optimal cardiovascular outcomes? J Clin Hypertens. 2011 Apr;25(4):211-7.
  46. Weir MR, Aronson S, Avery EG, Pollack CV Jr. Acute kidney injury following cardiac surgery: role of perioperative blood pressure control. Am J Nephrol. 2011;33(5):438-52.
  47. Weir MR, Hsueh WA, Nesbitt SD, Littlejohn TJ 3rd, Graff A, et. al. A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide. J Clin Hypertens (Greenwich). 2011 Jun;13(6):404-12.
  48. Weir MR and Salzberg Daniel J.  Management of hypertension in the transplant patient. JASH 2011 5(5):425-432.
  49. Weir MR, Hollenberg NK, Remuzzi G, Zappe DH, Meng X, Parving HH. Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients. J Hypertens. 2011 Aug 11 (Epub ahead of print).
  50. Weir MR. Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success? Kidney Int. 2011 Aug;80(3):235-7.
  51. Weir MR, Townsend RR, Fink JC, Teal V, Anderson C, Appel L, et. al. Hemodynamic Correlates of Proteinuria in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2011 Aug 18. (Epub ahead of print).
  52. Weir MR, Izzo JL Jr. Angiotensin-converting enzyme inhibitors. J Clin Hypertens (Greenwich). 2011 Sep;13(9):667-75.
  53. Weir MR. Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration. Kidney Int. 2011 Nov;10(2):1016-1017.
  54. Weir MR. Optimal Treatment Strategies for Patients with Hypertension and Diabetes Are Effects on Metabolism Important? Hypertension. 2011;58:789-759.
  55. Weir MR. Body mass index-mortality paradox in hemodialysis patients: blood pressure, blood volume, and nutritional status. Hypertension. 2011 Dec;58(6):989-90.

Non Peer-Reviewed

  1. Weir MR. Leadership message: government and corporate responsibility to work with academia about the obesity epidemic. J Clin Hypertens (Greenwich). 2011 March;13(3):217-8.
  2. Weir MR. The author replies. Kidney Int. 2011 June;79(12):1379-80.

Books

  1. Weir MR.  Evidence-based Management of Hypertension. Tfm Pub Ltd, Castle Hill Barns, Harley, Shrewsbury, UK, 2010.